Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Betamethasone

Psychomotor agitation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

An 8-year-old boy developed psychomotor agitation during treatment with betamethasone for chronic urticaria (CU). The boy, who had CU, started receiving treatment with betamethasone 4mg daily [route not stated]. Additionally, he was receiving treatment with budesonide/formoterol [budesonide/formoterol fumarate dehydrate], cetirizine, montelukast, unspecified antihistamine and unspecified anti-leukotriene. Subsequently, his CU had temporarily regressed. However, betamethasone was discontinued due to poor tolerance and psychomotor agitation induction [duration of treatment to reaction onset and outcome not stated]. …
Metadaten
Titel
Betamethasone
Psychomotor agitation: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65831-8

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Abaloparatide

Case report

Cotrimoxazole

Case report

Alteplase